Cost and appropriateness of treating asthma with fixed-combination drugs in local health care units in Italy | Zendy

Giorgio Lorenzo Colombo | Zendy; Isabella Ruggeri | Zendy; Donatello Bragato | Zendy; Emanuela Valla | Zendy; Di Matteo | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Cost and appropriateness of treating asthma with fixed-combination drugs in local health care units in Italy

Author(s) -

Giorgio Lorenzo Colombo,

Isabella Ruggeri,

Donatello Bragato,

Emanuela Valla,

Di Matteo

Publication year - 2012

Publication title -

clinicoeconomics and outcomes research

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.591

H-Index - 27

ISSN - 1178-6981

DOI - 10.2147/ceor.s36499

Subject(s) - medicine , asthma , medical prescription , health care , population , obstructive lung disease , pediatrics , emergency medicine , environmental health , pulmonary disease , pharmacology , economics , economic growth

Bronchial asthma is a chronic airways disease and is considered to be one of the major health problems in the Western world. During the last decade, a significant increase in the use of β2-agonists in combination with inhaled corticosteroids has been observed. The aim of this study was to assess the appropriateness of expenditure on these agents in an asthmatic population treated in a real practice setting.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research